AUR200, Isotone Natriumchloridlösung 0,9 % Braun Injektionslösung clinical trials

A Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of Aritinercept, a Dual BAFF/APRIL Inhibitor, in Patients with Generalized Myasthenia Gravis

This study is testing a new medicine called Aritinercept for people with a muscle weakness condition called Myasthenia Gravis. Researchers want to see if it's safe, how well it works, and how your body reacts to it over time. This is an early-stage study.